CymaBay Therapeutics, Inc.

JANE STREET GROUP, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/15/2024

Shares

194,968

Value ($000)

4,605

Weight

0.0%

2019 Q4 - 2023 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/15/2024	4,605	0.0%	194,968	12/31/2023
2023 Q3	11/15/2023	874	0.0%	58,648	9/30/2023
2023 Q2	8/14/2023	292	0.0%	26,638	6/30/2023
2023 Q1	5/16/2023	4,983	0.0%	571,499	3/31/2023
2022 Q4	2/15/2023	713	0.0%	113,683	12/31/2022
2022 Q3	11/15/2022	39	0.0%	11,253	9/30/2022
2022 Q2	8/16/2022	36	0.0%	12,252	6/30/2022
2021 Q2	8/16/2021	66	0.0%	15,085	6/30/2021
2021 Q1	5/18/2021	163	0.0%	35,932	3/31/2021
2020 Q4	2/17/2021	645	0.0%	112,363	12/31/2020
2020 Q3	11/17/2020	349	0.0%	48,244	9/30/2020
2019 Q4	2/14/2020	155	0.0%	78,903	12/31/2019